Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Eloxx Pharmaceuticals, Inc. (ELOX) common stock is the subject of an amended beneficial-ownership report from Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC and control person Matthew D. Perry. Each reports 422,716 shares, or 9.99%; these are identical reported amounts, not a combined total.
The reported amount includes shares issuable upon exercise of pre-funded warrants held directly by the Partnership and is subject to a 9.99% beneficial ownership limitation; warrant shares above that limit are excluded. The calculation uses 4,036,459 ELOX shares outstanding as of August 7, 2026. The Partnership holds the shares for its investors and has the right to receive or direct dividends and sale proceeds.
Key Figures
Beneficial ownership reported by each person:422,716 sharesPercent of class reported:9.99%Shares outstanding:4,036,459 shares
3 metrics
Beneficial ownership reported by each person422,716 sharesEach of the five reporting persons reports the same amount of ELOX common stock, including shares issuable upon exercise of pre-funded warrants.
Percent of class reported9.99%Reported by each reporting person; the calculation is subject to a 9.99% beneficial ownership limitation.
Shares outstanding4,036,459 sharesELOX common shares outstanding as of August 7, 2026; used in the ownership calculation.
"shares issuable upon the exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficial ownership limitationregulatory
"subject to the beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting powerregulatory
"Shared Voting Power 422,716.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 422,716.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ELOX shares do the Coastlands reporting persons report owning?
Each of the five reporting persons reports beneficial ownership of 422,716 shares, or 9.99% of the class. The reported amount includes shares issuable upon exercise of pre-funded warrants held directly by Coastlands Capital Partners LP.
How is the reported ELOX ownership percentage calculated?
The calculation uses 4,036,459 shares outstanding as of August 7, 2026, plus shares issuable upon exercise of pre-funded warrants, subject to a 9.99% beneficial ownership limitation. Warrants that would result in ownership above that limit are excluded from the reported amount.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Eloxx Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
29014R103
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
29014R103
1
Names of Reporting Persons
Coastlands Capital LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
422,716.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
422,716.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
422,716.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
IA, PN
Comment for Type of Reporting Person: Consists of shares of Common Stock, including shares of Common Stock issuable upon the exercise of pre-funded warrants, held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 4,036,459 shares of Common Stock outstanding as of August 7, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on August 11, 2026, plus the shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, subject to the beneficial ownership limitation of 9.99%. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation.
This Amendment No. 1 to Schedule 13G is being filed to reflect transactions in Common Stock.
SCHEDULE 13G
CUSIP Number(s):
29014R103
1
Names of Reporting Persons
Coastlands Capital Partners LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
422,716.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
422,716.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
422,716.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Consists of shares of Common Stock, including shares of Common Stock issuable upon the exercise of pre-funded warrants, held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 4,036,459 shares of Common Stock outstanding as of August 7, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on August 11, 2026, plus the shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, subject to the beneficial ownership limitation of 9.99%. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation.
This Amendment No. 1 to Schedule 13G is being filed to reflect transactions in Common Stock.
SCHEDULE 13G
CUSIP Number(s):
29014R103
1
Names of Reporting Persons
Coastlands Capital GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
422,716.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
422,716.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
422,716.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Consists of shares of Common Stock, including shares of Common Stock issuable upon the exercise of pre-funded warrants, held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 4,036,459 shares of Common Stock outstanding as of August 7, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on August 11, 2026, plus the shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, subject to the beneficial ownership limitation of 9.99%. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation.
This Amendment No. 1 to Schedule 13G is being filed to reflect transactions in Common Stock.
SCHEDULE 13G
CUSIP Number(s):
29014R103
1
Names of Reporting Persons
Coastlands Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
422,716.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
422,716.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
422,716.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, OO
Comment for Type of Reporting Person: Consists of shares of Common Stock, including shares of Common Stock issuable upon the exercise of pre-funded warrants, held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 4,036,459 shares of Common Stock outstanding as of August 7, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on August 11, 2026, plus the shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, subject to the beneficial ownership limitation of 9.99%. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation.
This Amendment No. 1 to Schedule 13G is being filed to reflect transactions in Common Stock.
SCHEDULE 13G
CUSIP Number(s):
29014R103
1
Names of Reporting Persons
Matthew D. Perry
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
422,716.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
422,716.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
422,716.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: Consists of shares of Common Stock, including shares of Common Stock issuable upon the exercise of pre-funded warrants, held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 4,036,459 shares of Common Stock outstanding as of August 7, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on August 11, 2026, plus the shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, subject to the beneficial ownership limitation of 9.99%. Excludes shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation.
This Amendment No. 1 to Schedule 13G is being filed to reflect transactions in Common Stock.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Eloxx Pharmaceuticals, Inc.
(b)
Address of issuer's principal executive offices:
P.O. Box 274, 10 Court Street Arlington, MA 02476
Item 2.
(a)
Name of person filing:
Coastlands Capital LP, a Delaware limited partnership ("Coastlands")
Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership")
Coastlands Capital GP LLC, a Delaware limited liability company (the "General Partner")
Coastlands Capital LLC, a Delaware limited liability company ("Coastlands GP")
Matthew D. Perry
Coastlands and the General Partner are the investment adviser and general partner, respectively, of the Partnership. Coastlands GP is the general partner of Coastlands. Mr. Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein. In addition, the filing of this Schedule 13G on behalf of the Partnership should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
601 California Street, Suite 1210, San Francisco, CA 94108
(c)
Citizenship:
See Item 4 of the cover sheet for each reporting person.
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP No.:
29014R103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Coastlands: 422,716
Partnership: 422,716
General Partner: 422,716
Coastlands GP: 422,716
Matthew D. Perry: 422,716
(b)
Percent of class:
Coastlands: 9.99%
Partnership: 9.99%
General Partner: 9.99%
Coastlands GP: 9.99%
Matthew D. Perry: 9.99%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Coastlands: 0
Partnership: 0
General Partner: 0
Coastlands GP: 0
Matthew D. Perry: 0
(ii) Shared power to vote or to direct the vote:
Coastlands: 422,716
Partnership: 422,716
General Partner: 422,716
Coastlands GP: 422,716
Matthew D. Perry: 422,716
(iii) Sole power to dispose or to direct the disposition of:
Coastlands: 0
Partnership: 0
General Partner: 0
Coastlands GP: 0
Matthew D. Perry: 0
(iv) Shared power to dispose or to direct the disposition of:
Coastlands: 422,716
Partnership: 422,716
General Partner: 422,716
Coastlands GP: 422,716
Matthew D. Perry: 422,716
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Partnership holds the shares of Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants, for the benefit of its investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares of Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Coastlands Capital LP
Signature:
/s/ Mark Shamia
Name/Title:
Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:
11/13/2026
Coastlands Capital Partners LP
Signature:
/s/ Mark Shamia
Name/Title:
Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:
11/13/2026
Coastlands Capital GP LLC
Signature:
/s/ Mark Shamia
Name/Title:
Chief Operating Officer
Date:
11/13/2026
Coastlands Capital LLC
Signature:
/s/ Mark Shamia
Name/Title:
Chief Operating Officer
Date:
11/13/2026
Matthew D. Perry
Signature:
/s/ Matthew D. Perry
Name/Title:
Reporting Person
Date:
11/13/2026
Exhibit Information
Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G (incorporated by reference to the Schedule 13G filed on June 17, 2026).
